Inhibition of multidrug-resistant HIV-1 by interference with cellular S-adenosylmethionine decarboxylase activity

Journal of Infectious Diseases

Volumn 194, Issue 6, 2006, Pages 740-750

  Schäfer, Birgit ^a   Hauber, Ilona ^a   Bunk, Andrea ^a   Heukeshoven, Jochen ^a   Düsedau, Arne ^a   Bevec, Dorian ^b   Hauber, Joachim ^a  

^a LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^b mondoBIOTECH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 (AMINOIMINOMETHYL) 2,3 DIHYDRO 1H INDENE 1 DIAMINOMETHYLENEHYDRAZONE; ADENOSYLMETHIONINE DECARBOXYLASE; ENZYME INHIBITOR; HYPUSINE; INITIATION FACTOR 5A; PROTEINASE INHIBITOR; REV PROTEIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAM 486A; SPERMIDINE; SPERMINE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL METABOLISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MULTIDRUG RESISTANCE; POLYAMINE SYNTHESIS; PRIORITY JOURNAL; PROGENY; VIRUS INHIBITION; VIRUS REPLICATION;

ADENOSYLMETHIONINE DECARBOXYLASE; AMIDINES; ANTIBODIES, VIRAL; CELL LINE; CELL SURVIVAL; DNA PRIMERS; DRUG RESISTANCE, VIRAL; ENZYME INHIBITORS; GENES, REV; HIV-1; HUMANS; INDANS; PEPTIDE INITIATION FACTORS; POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; TRANS-ACTIVATION (GENETICS); VIRUS REPLICATION;

EID: 33748422048     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/507043     Document Type: Article

References (50)

1. Tabor CW, Tabor H. Polyamines. Annu Rev Biochem 1984; 53:749-90.
2. Janne J, Alhonen L, Leinonen P. Polyamines: from molecular biology to clinical applications. Ann Med 1991; 23:241-59.
3. Regenass U, Mett H, Stanek J, Mueller M, Kramer D, Porter CW. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity. Cancer Res 1994; 54:3210-7.
4. McCann PP, Pegg AE. Ornithine decarboxylase as an enzyme target for therapy. Pharmacol Ther 1992; 54:195-215.
5. Pegg AE, McCann PP. S-adenosylmethionine decarboxylase as an enzyme target for therapy. Pharmacol Ther 1992; 56:359-77.
6. Thomas T, Thomas TJ. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci 2001; 58:244-58.
7. Thomas T, Thomas TJ. Polyamine metabolism and cancer. J Cell Mol Med 2003; 7:113-26.
8. Park MH, Wolff EC, Folk JE. Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation. Biofactors 1993; 4:95-104.
9. Bevec D, Jaksche H, Oft M, et al. Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor eIF-5A. Science 1996; 271:1858-60.
10. Hofmann W, Reichart B, Ewald A, et al. Cofactor requirements for nuclear export of Rev response element (RRE)- and constitutive transport element (CTE)-containing retroviral RNAs: an unexpected role for actin. J Cell Biol 2001; 152:895-910.
11. Hauber I, Bevec D, Heukeshoven J, et al. Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy. J Clin Invest 2005; 115:76-85.
12. Hart RA, Billaud JN, Choi SJ, Phillips TR. Effects of 1,8-diaminooctane on the FIV Rev regulatory system. Virology 2002; 304:97-104.
13. Andrus L, Szabo P, Grady RW, et al. Antiretroviral effects of deoxyhypusyl hydroxylase inhibitors: a hypusine-dependent host cell mechanism for replication of human immunodeficiency virus type 1 (HIV-1). Biochem Pharmacol 1998; 55:1807-18.
14. Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 1986; 233:215-9.
15. Chesebro B, Wehrly K, Nishio J, Perryman S. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J Virol 1992; 66:6547-54.
16. Hauber I, Harrer T, Löw P, Schmitt M, Schwingel E, Hauber J. Determination of HIV-1 circular DNA as a surrogate marker for residual virus replication in patients with undetectable virus loads. AIDS 2000; 14:2619-21.
17. Ciminale V, Felber BK, Campbell M, Pavlakis GN. A bioassay for HIV-1 based on Env-CD4 interaction. AIDS Res Hum Retroviruses 1990; 6:1281-7.
18. Daelemans D, Afonina E, Nilsson J, et al. A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export. Proc Natl Acad Sci USA 2002; 99:14440-5.
19. Ruhl M, Himmelspach M, Bahr GM, et al. Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation. J Cell Biol 1993; 123:1309-20.
20. Malim MH, Hauber J, Fenrick R, Cullen BR. Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes. Nature 1988; 335:181-3.
21. Berger J, Hauber J, Hauber R, Geiger R, Cullen BR. Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 1988; 66:1-10.
22. Swanson CM, Puffer BA, Ahmad KM, Doms RW, Malim MH. Retroviral mRNA nuclear export elements regulate protein function and virion assembly. EMBO J 2004; 23:2632-40.
23. Mi Z, Kramer DL, Miller JT, Bergeron RJ, Bernacki R, Porter CW. Human prostatic carcinoma cell lines display altered regulation of polyamine transport in response to polyamine analogs and inhibitors. Prostate 1998; 34:51-60.
24. Gutman M, Beltran PJ, Fan D, et al. Treatment of nude mice with 4-amidinoindan-1-one2′-amidinohydrazone, a new S-adenosylmethionine decarboxylase inhibitor, delays growth and inhibits metastasis of human melanoma cells. Melanoma Res 1995; 5:147-54.
25. Dorhout B, te Velde RJ, Ferwerda H, Kingma AW, de Hoog E, Muskiet FA. In vivo growth inhibition of L1210 leukemia by 4-amidinoindan-1-one 2′-amidinohydrazone (CGP 48664A), a new inhibitor of S-adenosylmethionine decarboxylase. Int J Cancer 1995; 61:214-7.
26. Hu X, Washington S, Verderame MF, Demers LM, Mauger D, Manni A. Biological activity of the S-adenosylmethionine decarboxylase inhibitor SAM486A in human breast cancer cells in vitro and in vivo. Int J Oncol 2004; 25:1831-8.
27. Zhou H, Choi L, Lau H, et al. Population pharmacokinetics/toxico-dynamics (PK/TD) relationship of SAM486A in phase I studies in patients with advanced cancers. J Clin Pharmacol 2000; 40:275-83.
28. Siu LL, Rowinsky EK, Hammond LA, et al. A phase I and pharmacokinetic study of SAM486A, a novel polyamine biosynthesis inhibitor, administered on a daily-times-five every-three-week schedule in patients with advanced solid malignancies. Clin Cancer Res 2002; 8:2157-66.
29. Paridaens R, Uges DR, Barbet N, et al. A phase I study of a new polyamine biosynthesis inhibitor, SAM486A, in cancer patients with solid tumours. Br J Cancer 2000; 83:594-601.
30. Millward MJ, Joshua A, Kefford R, et al. Multi-centre phase II trial of the polyamine synthesis inhibitor SAM486A (CGP48664) in patients with metastatic melanoma. Invest New Drugs 2005; 23:253-6.
31. Pless M, Belhadj K, Menssen HD, et al. Clinical efficacy, tolerability, and safety of SAM486A, a novel polyamine biosynthesis inhibitor, in patients with relapsed or refractory non-Hodgkin's lymphoma: results from a phase II multicenter study. Clin Cancer Res 2004; 10:1299-305.
32. Walter H, Schmidt B, Korn K, Vandamme AM, Harrer T, Überla K. Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors. J Clin Virol 1999; 13:71-80.
33. Klier H, Csonga R, Joao HC, et al. Isolation and structural characterization of different isoforms of the hypusine-containing protein eIF-5A from HeLa cells. Biochemistry 1995; 34:14693-702.
34. Park MH, Wolff EC, Folk JE. Is hypusine essential for eukaryotic cell proliferation? Trends Biochem Sci 1993; 18:475-9.
35. Pollard VW, Malim MH. The HIV-1 Rev protein. Annu Rev Microbiol 1998; 52:491-532.
36. Strebel K. Virus-host interactions: role of HIV proteins Vif, Tat, and Rev. AIDS 2003; 17(Suppl 4):S25-S34.
37. Rodriguez MS, Dargemont C, Stutz F. Nuclear export of RNA. Biol Cell 2004; 96:639-55.
38. Wodrich H, Schambach A, Kräusslich HG. Multiple copies of the Mason-Pfizer monkey virus constitutive RNA transport element lead to enhanced HIV-1 Gag expression in a context-dependent manner. Nucleic Acids Res 2000; 28:901-10.
39. Izaurralde E. Directing mRNA export. Nat Struct Mol Biol 2004; 11:210-2.
40. Palella FJ Jr., Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338:853-60.
41. Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Ann Intern Med 2002; 137:381-433.
42. Wensing AM, Boucher CA. Worldwide transmission of drug-resistant HIV. AIDS Rev 2003; 5:140-55.
43. Kramer D, Mett H, Evans A, Regenass U, Diegelman P, Porter CW. Stable amplification of the S-adenosylmethionine decarboxylase gene in Chinese hamster ovary cells. J Biol Chem 1995; 270:2124-32.
44. Tolbert WD, Ekstrom JL, Mathews II, et al. The structural basis for substrate specificity and inhibition of human S-adenosylmethionine decarboxylase. Biochemistry 2001; 40:9484-94.
45. Shantz LM, Pegg AE. Assay of mammalian S-adenosylmethionine decarboxylase activity. Methods Mol Biol 1998; 79:45-9.
46. Pegg AE, Xiong H, Feith DJ, Shantz LM. S-adenosylmethionine decarboxylase: structure, function and regulation by polyamines. Biochem Soc Trans 1998; 26:580-6.
47. Marton LJ, Pegg AE. Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 1995; 35:55-91.
48. Chiang PK, McCann PP, Lane JR, Pankaskie MC, Burke DS, Mayers DL. Antihuman Immunodeficiency Virus (HIV-1) activities of inhibitors of polyamine pathways. J Biomed Sci 1996; 3:78-81.
49. Rosorius O, Reichart B, Krätzer F, Heger P, Dabauvalle MC, Hauber J. Nuclear pore localization and nucleocytoplasmic transport of eIF-5A: evidence for direct interaction with the export receptor CRM1. J Cell Sci 1999; 112:2369-80.
50. Lipowsky G, Bischoff FR, Schwarzmaier P, et al. Exportin 4: a mediator of a novel nuclear export pathway in higher eukaryotes. EMBO J 2000; 19:4362-71.